Organogenesis Holdings Inc. announced the appointments of Michele Korfin and Gilberto Quintero, Ph.D. to the Company's Board of Directors, effective May 3, 2022. Ms. Korfin and Dr. Quintero will serve as independent directors of the Company. With the appointment of Ms. Korfin and Dr. Quintero, the Company's board of directors has a majority of independent directors.

Michele Korfin joined Gamida Cell's leadership team as Chief Operating and Chief Commercial Officer in 2020. Prior to Gamida Cell, Michele served as Chief Operating Officer at TYME Technologies. Gilberto Quintero, Ph.D. has served as Chief Quality Officer of Global Quality, Regulatory and Compliance at Kimberly-Clark since 2019.

Before joining Kimberly-Clark, Gilberto spent more than a decade at Cardinal Health in roles of increasing responsibility most recently serving as Chief Quality and Regulatory Affairs Officer for Pharmaceuticals and Medical Devices.